Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery

Vaccine

Volumn 17, Issue 3, 1999, Pages 252-260

  Arulanandam, Bernard P ^a   Metzger, Dennis W ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

IL 12; Intranasal; Mucosal

Indexed keywords

2,4 DINITROPHENOL; CHOLERA TOXIN B SUBUNIT; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 5; OVALBUMIN;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FECES LEVEL; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; INTRANASAL DRUG ADMINISTRATION; LUNG LAVAGE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; TISSUE LEVEL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; FECES; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; INTERLEUKIN-12; LUNG; MICE; MICE, INBRED BALB C; NASAL MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TH1 CELLS;

EID: 0345267406     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00157-1     Document Type: Article

References (43)

1. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 12:1994;387-400.
2. Kobayashi M., Fitz L., Ryan M.et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:1989;827-845.
3. Macatonia S.E., Hosken N.A., Litton M. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154:1995;5071-5079.
4. Trinchieri G., Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 146:1995;423-431.
5. Buchanan J.M., Vogel L.A., Van Cleave V.H., Metzger D.W. Interleukin 12 alters the isotype-restricted antibody response of mice to hen eggwhite lysozyme. Int. Immunol. 7:1995;1519-1528.
6. Metzger D.W., Buchanan J.M., Collins J.T.et al. Enhancement of humoral immunity by interleukin-12. Ann. NY Acad. Sci. 795:1996;100-115.
7. Metzger D.W., McNutt R.M., Collins J.T., Buchanan J.M., Van Cleave V.H., Dunnick W.A. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-γ-dependent and-independent mechanisms. Eur. J. Immunol. 27:1997;1958-1965.
8. McKnight A.J., Zimmer G.J., Fogelman I., Wolf S.F., Abbas A.K. Effects of IL-12 on helper T-cell-dependent immune responses in vivo. J. Immunol. 152:1994;2172-2179.
9. Morris S.C., Madden K.B., Adamovicz J.J.et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1994;1047-1056.
10. Germann T., Bongartz M., Dlugonska H.et al. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:1995;823-829.
11. Wynn T.A., Reynolds A., James S.et al. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J. Immunol. 157:1996;4068-4078.
12. Bliss J., Van Cleave V., Murray K.et al. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:1996;887-894.
13. Buchanan RM, Arulanandam BP, Metzger DW. Interleukin 12 enhances antibody responses to T-independent polysaccharide antigens in the absence of T and NK cells. J. Immunol., in press.
14. Yang Y., Trinchieri G., Wilson J.M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1:1995;890-893.
15. Marinaro M., Boyaka P.N., Finkelman F.D.et al. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 185:1997;415-427.
16. Nedrud J.G., Liang X.P., Hague N., Lamm M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 139:1987;3484-3492.
17. Liang X.P., Lamm M.E., Nedrud J.G. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice. Reg. Immunol. 2:1989;244-248.
18. Wu H.Y., Russell M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:1993;314-322.
19. Russell M.W., Moldoveanu Z., White P.L., Sibert G.J., Mestecky J., Michalek S.M. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64:1996;1272-1283.
20. deVos T., Dick T.A. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. Immunol. Meth. 141:1991;285-288.
21. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
22. Coffman R.L., Varkila K., Scott P., Chatelain R. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol. Rev. 123:1991;189-207.
23. Meyaard L., Hovenkamp E., Otto S.A., Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 156:1996;2776-2782.
24. Daftarian P.M., Kumar A., Kryworuchko M., Diaz-Mitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α J. Immunol. 157:1996;12-20.
25. Gerosa F., Paganin C., Peritt D.et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J. Exp. Med. 183:1996;2559-2569.
26. Sher A., Jankovic D., Cheever A., Wynn T. An IL-12-based vaccine approach for preventing immunopathology in schistosomiasis. Ann. NY Acad. Sci. 795:1996;202-207.
27. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-γ Annu. Rev. Immunol. 15:1997;749-795.
28. Snapper C.M., Paul W.E. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236:1987;944-947.
29. Snapper C.M., Peschel C., Paul W.E. IFN-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140:1988;2121-2127.
30. Finkelman F.D., Katona I.M., Mosmann T.R., Coffman R.L. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1988;1022-1027.
31. Fiorentino D.F., Zlotnik A., Vieira P.et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:1991;3444-3451.
32. Ding L., Shevach E.M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:1992;3133-3139.
33. Manetti R., Parronchi P., Giudizi M.G.et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1993;1199-1204.
34. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
35. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today. 14:1993;335-338.
36. Finkelman F.D., Holmes J., Katona I.M. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:1990;303-333.
37. Snapper C.M., McIntyre T.M., Mandler R.et al. Induction of IgG3 secretion by interferon γ: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J. Exp. Med. 175:1992;1367-1371.
38. Collins J.T., Dunnick W.A. Germline transcripts of the murine immunoglobulin γ2a gene: structure and induction by IFN-γ Int. Immunol. 5:1993;885-891.
39. Okada E., Sasaki S., Ishii N.et al. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638-3647.
40. Van Regenmortel M. Searching for safer, more potent, better-targeted adjuvants. ASM News. 63:1997;136-139.
41. Gupta, R.K., Griffin P. Jr., Chang, A.C., et al., The role of adjuvants and delivery systems in modulation of immune response to vaccines. In: Cohen, S., Shafferman, A. (Eds.), Novel Strategies in Design and Production of Vaccines. Plenum Press, New York, 1996 pp. 105-113.
42. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:1989;59-72.
43. Palladino G., Mozdzanowska K., Washko G., Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69:1995;2075-2081.